Bringing the fundamentals into focus…
Back to Janux Therapeutics, Inc.
How Janux Therapeutics, Inc. stacks up
JANX · against 1,216 other Healthcare companies
Growth
95/ 100
Near the top of its peers.
Ranked #56 of 1,217 · scores higher than 95% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including JANX · Click a bar to see the companies
Why growth scores 95?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 45.7% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 100% of peers. Revenue growth: 5367.0% vs peer median 6.1%
Metric by metric
Position: dot = JANX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JANX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 5367.0% | 6.1% | 100% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 45.7% | 5.8% | 92% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around JANX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 56 | 274M USD | 95 | 57 | |
| 56 | 9.0B USD | 95 | 51 | |
| 56 | 3.0B USD | 95 | 54 | |
| 56 | 22.8B USD | 95 | 38 | |
| 56 | 1.1B USD | 95 | 50 | |
| 56 | 1.6B USD | 95 | 38 | |
| 56 | 2.0B USD | 95 | 53 | |
| 56 | 1.3B USD | 95 | 33 | |
| 56 | 467M USD | 95 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score